Biopharmaceutical Equities

Companies
China Universal Asset Management Co. Ltd. Increases Stake in Vanda Pharmaceuticals Nov 1, 2024
Earnings
GENFIT Announces Solid H1 2024 Financials and Key Corporate Developments Sep 20, 2024
Finance
Bronstein, Gewirtz & Grossman, LLC Initiates Investigation into Liquidia Technologies, Inc. for Potential Investor Claims Sep 3, 2024
Companies
Immuron Limited CEO, Steven Lydeamore, to Present at the Emerging Growth Conference Aug 16, 2024
Companies
Nektar Therapeutics NKTR Faces Q2 Earnings Shortfall, Despite Revenue Surge Aug 10, 2024
Companies
NurExone Biologic Inc. Springs Forward with Key Initiatives: Growth Conference Highlights and Website Overhaul Jul 6, 2024
StockNews.com Begins Analysis of Vanda Pharmaceuticals VNDA Jul 5, 2024
Biotechnology
NurExone Biologic Targets Glaucoma with ExoPTEN in Pre-Clinical Study for Multi-Billion Dollar Market Jun 30, 2024
Pharmaceuticals
Ardelyx Showcases Further Evidence of IBSRELA® Efficacy at 2024 Digestive Disease Week May 21, 2024
Stocks
Cognition Therapeutics Concludes $11.5 Million Public Offering Mar 15, 2024
Stocks
Halozyme Therapeutics HALO Upgraded to 'Buy' Status Amid Positive Market Outlook Feb 24, 2024
Pharmaceuticals
Liquidia Corporation Announces FDA Update on YUTREPIA™ Inhalation Powder NDA Jan 25, 2024
Finance
Liquidia Corporation Secures $100 Million Boost through New Financial Agreements Jan 5, 2024
Companies
Ardelyx Sets Date for Update on IBSRELA® and IBS-C Sector Expert Discussion Jan 4, 2024
Companies
Ardelyx Announces Upcoming Update on IBSRELA® and Expert Discussion on IBS-C Market Jan 3, 2024
Stocks
Assessing the Investment Appeal of Select Dow Stocks in 2024 Dec 30, 2023
Finance
Vandria Secures $20.6M in Series A Funding to Propel CNS Clinical Program and Mitochondrial Therapeutics Development Dec 15, 2023
Markets
U.S. Stock Market Sees Broad Gains; Verint Outperforms with Strong Earnings Dec 7, 2023
Companies
Cytokinetics to Present Multiple Studies at the 34th International ALS/MND Symposium Nov 30, 2023
Earnings
CytoMed Therapeutics Announces H1 2023 Financial Results and Provides Company Update Nov 18, 2023